4//SEC Filing
Nicholson John 4
Accession 0001209191-18-018221
CIK 0000906709other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 6:09 PM ET
Size
7.2 KB
Accession
0001209191-18-018221
Insider Transaction Report
Form 4
Nicholson John
SVP & Chief Financial Officer
Transactions
- Sale
Common Stock
2018-03-06$98.29/sh−120,000$11,794,800→ 267,657 total - Sale
Common Stock
2018-03-07$100.45/sh−100,144$10,059,465→ 167,513 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $98.00 to $100.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
- [F2]This transaction was executed in multiple trades at prices ranging from $99.00 to $101.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
Documents
Issuer
NEKTAR THERAPEUTICS
CIK 0000906709
Entity typeother
Related Parties
1- filerCIK 0001420766
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 6:09 PM ET
- Size
- 7.2 KB